Clinical Trial Update: CaveoVasc System - a New Femoral Vascular Access and Closure Device [NA]

View source ↗

Summary

A clinical trial for the CaveoVasc System, a femoral vascular access and closure device, has been terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheterization Via Femoral Sheath 6 Fr

Drugs mentioned

• CaveoVasc System

Snippet

Sponsor: CaveoMed GmbH | Conditions: Catheterization Via a Femoral Sheath ≤ 6Fr | NA | Status: TERMINATED | Results posted: 2018-08-28